Rafael Holdings RFL
NYSE RFL
$2.29 -0.14 (-5.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) Exchange Rate Effect (2017 - 2026)

Rafael Holdings' (RFL) quarterly Exchange Rate Effect came in at $24000.0 in Q2 2026, down 52.0% quarter-over-quarter from $50000.0 in Q1 2026.

Analysis

Rafael Holdings (RFL) Exchange Rate Effect (2017 - 2026) Analysis & Trends

Rafael Holdings (RFL) has reported Exchange Rate Effect for 10 consecutive years, with $24000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Exchange Rate Effect changed N/A year-over-year to $24000.0 in Q2 2026; TTM through Apr 2026 was $109000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $153000.0, up 795.45% from the prior year.
  • Exchange Rate Effect was $24000.0 for Q2 2026 at Rafael Holdings, down from $50000.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $191000.0 in Q1 2024 and troughed at -$276000.0 in Q2 2023.
  • A 5-year average of -$24466.7 and a median of $24000.0 in 2026 frame the typical range for Exchange Rate Effect.
  • Across the five-year window, Exchange Rate Effect tumbled 4700.0% in 2022 and surged 3700.0% in 2025, its largest moves.
  • Over 5 years, Exchange Rate Effect stood at -$92000.0 in 2022, then tumbled by 105.43% to -$189000.0 in 2023, then surged by 99.47% to -$1000.0 in 2024, then surged by 3700.0% to $36000.0 in 2025, then plunged by 33.33% to $24000.0 in 2026.
  • The last three Exchange Rate Effect figures came in at $24000.0 (Q2 2026), $50000.0 (Q1 2026), and $36000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -19.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -3.70 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -300,000.00
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -2.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -2.45 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -3.40 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 315,000.00
10 Rafael Holdings 117.57 Mn 117.57 Mn 171,000.00 24,000.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 24,000.00
Jan 31, 2026 50,000.00
Oct 31, 2025 36,000.00
Oct 31, 2024 -1,000.00
Jul 31, 2024 26,000.00
Apr 30, 2024 -50,000.00
Jan 31, 2024 191,000.00
Oct 31, 2023 -189,000.00
Jul 31, 2023 133,000.00
Apr 30, 2023 -276,000.00
Jan 31, 2023 89,000.00
Oct 31, 2022 -92,000.00
Jul 31, 2022 -146,000.00
Apr 30, 2022 -211,000.00
Jan 31, 2022 49,000.00
Oct 31, 2021 2,000.00
Jul 31, 2021 97,000.00
Apr 30, 2021 7,000.00
Jan 31, 2021 21,000.00
Oct 31, 2020 -3,000.00